Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
155
NMPA:155
Drug Approvals
Papaverine Hydrochloride for Injection
- Product Name
- 注射用盐酸罂粟碱
- Approval Number
- 国药准字H20080667
- Approval Date
- Dec 2, 2022
NMPA
Compound Hepar Extract Tablets
- Product Name
- 复方肝水解物片
- Approval Number
- 国药准字H41025093
- Approval Date
- Dec 17, 2021
NMPA
Compound Sulfamethoxazole Tablets
- Product Name
- 复方磺胺甲噁唑片
- Approval Number
- 国药准字H41021598
- Approval Date
- Dec 17, 2021
NMPA
Calcium Folinate for Injection
- Product Name
- 注射用亚叶酸钙
- Approval Number
- 国药准字H41021710
- Approval Date
- Dec 17, 2021
NMPA
Pancreatin Enteric-coated Tablets
- Product Name
- 胰酶肠溶片
- Approval Number
- 国药准字H41022889
- Approval Date
- Dec 17, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found